18 March, 2014

Stamford Law advised TalkMed Group Limited in relation to its initial public offering and listing on the Catalist board of the SGX-ST to raise proceeds of approximately SGD 21m by way of a placement of 105,143,000 new shares at the issue price of SGD 0.20 each. The Stamford Law team was led by Lian Seng Yap.

 
TalkMed Group Limited provides medical oncology services to patients under the Parkway Cancer Centre brand name, through a contractual arrangement between its wholly-owned subsidiary, Singapore Cancer Centre Pte. Ltd. and Parkway Hospitals Singapore Pte. Ltd.

Conventus Law

Follow us on Twitter @conventuslaw